Altri progetti

  • POS 3 - "Sviluppo di una piattaforma per la implementazione clinica della oncologia di precisione nelle regioni del centro sud Italia” - Traiettoria 3, Principal Investigator Dott.ssa Stefania Tommasi
  • POS 4 - “Biotecnologia, bioinformatica e sviluppo farmaceutico per la reazione di un HUB delle Scienze della Vita” - Traiettoria 4 - Principal Investigator Dott. Attilio Guarini
  • Finalizzata - "PEERAD –PrEdicting Endopredict score with RADiomics: a novel radiomics model based on artificial intelligence to drive adjuvant treatment in patients with early-stage, intermediate-risk, hormone-receptor positive HER2 negative breast cancer”, Principal Investigator Dott.ssa Annarita Fanizzi
  • Finalizzata - "Definition and testing of a new model of clinical governance based on the integration of tools such as Health Technology Assessment, Clinical Practice Guidelines, Clinical Pathways, and healthcare performance measurement for planning, implementation and management of healthcare interventions in different settings - lNTEGRATE-HEALTH-GOV", Principal Investigator Dott. Francesco Giotta
  • Tecnopolo quarta annualità, T1.2.1 Development of Single molecule bio-electronic smart system array for the detection of several HPV biomarkers in body fluids, Principal Investigator Dott. Alfredo Zito
  • Tecnopolo quarta annualità, T1.2.2 LncRNAsfrom prostate cancer tissues, Principal Investigator Dott.ssa Amalia Azzariti
  • Tecnopolo quarta annualità, T1.2.3 miRNAs characterization in plasma samples of CSCC patients, Principal Investigator Dott.ssa Amalia Azzariti
  • Tecnopolo quarta annualità, T1.2.4 Prospective study of microenvironment in the different molecular subtypes of colon cancer, Principal Investigator Dott.ssa Stefania Tommasi
  • Tecnopolo quarta annualità, T1.3.1 EVs characterization in pre-explant samples of colon cancer patients, Principal Investigator Dott.ssa Amalia Azzariti
  • Tecnopolo quarta annualità, T1.3.2 Development of a microfluidic system for determining the selected subpopulation of circulating EVs from melanoma patients positive for PD1 or PD-L1 and released from melanoma cells, T cells and B cells, Principal Investigator Dott.ssa Amalia Azzariti
  • Tecnopolo quarta annualità, T2.2.1. New hydrogel for cancer PDOs generation, Principal Investigator Dott.ssa Amalia Azzariti
  • Tecnopolo quarta annualità, T2.2.2. Optimization of the establishment of haematological cancer PDOs and drug screening, Principal Investigator Dott. Attilio Guarini
  • Tecnopolo quarta annualità, T2.2.3. Design of melanoma and lung cancer single (tumor) and multi (tumor and lymph nodes) - organ-on-chip platforms to study tumor evolution and monitor therapeutic responses. Static single-organ-on-chip systems, Principal Investigator Dott. Michele Guida /Dott. Domenico Galetta
  • Tecnopolo quarta annualità, T4.1.1 Nonviral, biodegradable polymeric nanocarriers for personalised gene therapy, Principal Investigator Dott. Attilio Guarini
  • Tecnopolo quarta annualità, T4.3.1 Detection of HPVs in paired healthy skin, actinic keratosis, basal and squamous cell carcinoma, Principal Investigator Dott. Alfredo Zito
  • Tecnopolo quarta annualità, T4.3.3 Biomimetic drug delivery system, Principal Investigator Dott.ssa Amalia Azzariti
  • Tecnopolo quarta annualità, T5.1.2. Development and application of artificial intelligence-based diagnostic and prediction models in neurodegenerative and oncological diseases, Principal Investigator Dott.ssa Raffaella Massafra
  • Tecnopolo quarta annualità, T5.1.3. Development of novel approached to predict toxicity outcomes in radiotherapy, Principal Investigator Dott.ssa Raffaella Massafra
  • Conto capitale  Conto Capitale CC-2022- 23682641,  “Piattaforma di imaging confocale e trascrittomica spaziale”, Principal Investigator Dott.ssa Amalia Azzariti
  • ACC, ACC - ACCORD, the ACC Omics Registry: a digital environment to leverage observational cancer omics data to develop computer-assisted diagnostic and predictive models, Principal Investigator Dott.ssa Stefania Tommasi
  • ACC, The ACC Preclinical research platform for precision oncology, Principal Investigator Dott.ssa Amalia Azzariti
  • ACC, ACC “Piano esecutivo fondo attività reti- RCR-2022-23682296 ", Principal Investigator Dott.ssa Stefania Tommasi
  • Health Big Data HBD, “Istituti virtuali di patologia della Rete Italiana degli IRCCS: prevenire le malattie, personalizzare le cure, migliorare la qualità dela vita dei pazienti”         
  • Bandi a cascata, Omics landscape of gliomas by long-read sequencing, Principal Investigator Dott.ssa Stefania Tommasi
  • Bandi a cascata, Esame dei Composti volatili nel Cancro del Colon" (E.C.C.O.), Principal Investigator Dott.ssa Elisabetta   Martinelli
  • Bandi a cascata, Targeting Mir- 21 VIA RNA NANOTECHNOLOGY TO ENHANCE THE RESPONSE TO ANTI- PD1 IN LIVER CANCEER – Miracle, Principal Investigator Dott.ssa Rosella Fasano
  • TTO, Progetto Life Science TTO Network (PNC TT), Principal Investigator, Ing. Vito Angiulli. 

Documents